Abbott Laboratories (ABT) share buybacks: $893M
Abbott Laboratories spent $893M buying back its own shares in the year ended Dec 31, 2025, down 31.0% from $1.3B a year earlier.
From Abbott Laboratories's filings with the SEC · Read the filing · ABT stock page
Abbott Laboratories share buybacks by year
#236 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $893M | -31% |
| Dec 31, 2024 | $1.3B | +6% |
| Dec 31, 2023 | $1.2B | -68% |
| Dec 31, 2022 | $3.8B | +65% |
| Dec 31, 2021 | $2.3B | – |
Share buybacks of similar companies
Companies in the same industry as Abbott Laboratories, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Zoetis | $3.2B | Dec 31, 2025 |
| Vertex Pharmaceuticals Inc / Ma | $2B | Dec 31, 2025 |
| Royalty Pharma | $1.2B | Dec 31, 2025 |
| United Therapeutics | $1B | Dec 31, 2025 |
| AbbVie | $980M | Dec 31, 2025 |
| Abbott Laboratories | $893M | Dec 31, 2025 |
| Viatris | $500M | Dec 31, 2025 |
Questions and answers
What is Abbott Laboratories's share buybacks?
Abbott Laboratories spent $893M buying back its own shares in the year ended Dec 31, 2025, down 31.0% from $1.3B a year earlier.
Numbers as reported in Abbott Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology